An Experimental Drug for Duchenne Muscular Dystrophy Has Been Awarded Orphan Drug Status by the F.D.A.
Source: Pixabay

An Experimental Drug for Duchenne Muscular Dystrophy Has Been Awarded Orphan Drug Status by the F.D.A.

The U.S. Food and Drug Administration (FDA) has awarded Orphan Drug Designation to the experimental drug Sarconeos, developed by the company Biophytis, for the treatment of Duchenne muscular dystrophy. The…

Continue Reading An Experimental Drug for Duchenne Muscular Dystrophy Has Been Awarded Orphan Drug Status by the F.D.A.
Researchers Are Investigating a New Way to Monitor Disease Progression for People with Charcot-Marie-Tooth Disease Type 1
Source: Pixabay

Researchers Are Investigating a New Way to Monitor Disease Progression for People with Charcot-Marie-Tooth Disease Type 1

Researchers have found a new way to monitor disease progression in people with Charcot-Marie-Tooth disease type 1 (CMT1), reports Charcot Marie Tooth News. CMT1 is an inherited genetic condition that…

Continue Reading Researchers Are Investigating a New Way to Monitor Disease Progression for People with Charcot-Marie-Tooth Disease Type 1